DK2211180T3 - Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer - Google Patents

Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer

Info

Publication number
DK2211180T3
DK2211180T3 DK10158956.2T DK10158956T DK2211180T3 DK 2211180 T3 DK2211180 T3 DK 2211180T3 DK 10158956 T DK10158956 T DK 10158956T DK 2211180 T3 DK2211180 T3 DK 2211180T3
Authority
DK
Denmark
Prior art keywords
marker
cancers
colorectal cancer
satb2
protein
Prior art date
Application number
DK10158956.2T
Other languages
English (en)
Inventor
Mathias Uhlen
Fredrik Ponten
Original Assignee
Atlas Antibodies Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlas Antibodies Ab filed Critical Atlas Antibodies Ab
Application granted granted Critical
Publication of DK2211180T3 publication Critical patent/DK2211180T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK10158956.2T 2006-06-02 2007-06-04 Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer DK2211180T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06114954A EP1862803A1 (en) 2006-06-02 2006-06-02 Use of protein SATB2 as a marker for colorectal cancer
US81661306P 2006-06-27 2006-06-27
EP07725799A EP2024747B1 (en) 2006-06-02 2007-06-04 Use of protein satb2 as a prognostic marker for colorectal cancer

Publications (1)

Publication Number Publication Date
DK2211180T3 true DK2211180T3 (da) 2011-09-26

Family

ID=36968849

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07725799.6T DK2024747T3 (da) 2006-06-02 2007-06-04 Anvendelse af protein SATB2 som prognotisk markør for colerectal cancer
DK10158956.2T DK2211180T3 (da) 2006-06-02 2007-06-04 Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07725799.6T DK2024747T3 (da) 2006-06-02 2007-06-04 Anvendelse af protein SATB2 som prognotisk markør for colerectal cancer

Country Status (11)

Country Link
US (3) US8067190B2 (da)
EP (3) EP1862803A1 (da)
JP (2) JP4990970B2 (da)
CN (2) CN103293307B (da)
AT (2) ATE513216T1 (da)
AU (1) AU2007256391B2 (da)
CA (1) CA2653952A1 (da)
DK (2) DK2024747T3 (da)
ES (1) ES2367412T3 (da)
PL (1) PL2211180T3 (da)
WO (1) WO2007140966A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100662821B1 (ko) * 2006-04-05 2006-12-28 유니트마 주식회사 레시피언트 블록 성형용 몰드 및 이를 이용한 레시피언트블록의 제조방법
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
EP2107375A1 (en) * 2008-03-31 2009-10-07 Atlas Antibodies AB Uses of WARS protein in cancer prognostics
EP2172477A1 (en) * 2008-10-06 2010-04-07 Atlas Antibodies AB Epitopes derived from SATB2 and uses thereof
EP2396657B1 (en) * 2009-02-16 2013-11-13 Atlas Antibodies AB Rbm3 as a marker for malignant melanoma prognosis
CN106461669A (zh) * 2014-05-13 2017-02-22 瓦斯特空公司 外周血及其单核细胞中的甲硫氨酸氨肽酶过表达作为结肠直肠癌筛查、诊断和预后的标记物
US11326210B2 (en) * 2015-01-30 2022-05-10 Glax Llc Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
US20160258438A1 (en) * 2015-03-05 2016-09-08 Regal Beloit America, Inc. Assembly, blower and associated method
US20180282815A1 (en) * 2015-04-29 2018-10-04 Geneoscopy, Llc Colorectal cancer screening method and device
US11479820B2 (en) 2016-10-27 2022-10-25 Geneoscopy, Inc. Detection method using eukaryotic cells
CN106841131A (zh) * 2016-12-29 2017-06-13 上海交通大学 一种基于角蛋白自荧光作为预测检测肿瘤的生物标志物的检测方法及其应用
JP2021526375A (ja) 2018-06-01 2021-10-07 ジェネオスコピー インコーポレイテッド 検出方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828840D0 (en) 1998-12-30 1999-02-17 Univ Nottingham Trent Prostate cancer associated genes and their products
DE19932688B4 (de) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
AU2002332606A1 (en) * 2001-08-21 2003-03-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20090215711A1 (en) * 2004-04-30 2009-08-27 Sagres Discovery, Inc. Novel compositions and methods in cancer
DE102004037860A1 (de) * 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
CA2607133A1 (en) * 2005-05-02 2006-11-09 Toray Industries, Inc. Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
GB2435882A (en) 2006-03-09 2007-09-12 Bioinvent Int Ab Detection and treatment of mantle cell lymphoma
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer

Also Published As

Publication number Publication date
AU2007256391A1 (en) 2007-12-13
US8067190B2 (en) 2011-11-29
US20120270956A1 (en) 2012-10-25
JP5301630B2 (ja) 2013-09-25
DK2024747T3 (da) 2011-09-19
PL2211180T3 (pl) 2011-11-30
CN103293307A (zh) 2013-09-11
EP1862803A1 (en) 2007-12-05
EP2211180B1 (en) 2011-06-22
CN101460850A (zh) 2009-06-17
EP2024747B1 (en) 2011-06-15
JP2009539082A (ja) 2009-11-12
US8241859B2 (en) 2012-08-14
CA2653952A1 (en) 2007-12-13
US8465934B2 (en) 2013-06-18
ATE514090T1 (de) 2011-07-15
US20090220975A1 (en) 2009-09-03
JP2012073260A (ja) 2012-04-12
ES2367412T3 (es) 2011-11-03
US20120028836A1 (en) 2012-02-02
AU2007256391B2 (en) 2011-05-19
ATE513216T1 (de) 2011-07-15
EP2211180A1 (en) 2010-07-28
JP4990970B2 (ja) 2012-08-01
EP2024747A1 (en) 2009-02-18
CN103293307B (zh) 2016-03-23
WO2007140966A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
DK2211180T3 (da) Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer
WO2006089125A3 (en) Methods of detecting ovarian cancer
WO2010009368A3 (en) Compositions for the detection and treatment of colorectal cancer
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
CU24058B1 (es) Antagonistas de pcsk9
DK2438446T3 (da) Fremgangsmåder, reagenser og kits til flowcytometrisk immunfænotypebestemmelse
WO2010009337A3 (en) Signatures and pcdeterminants associated with prostate cancer and methods of use thereof
PL2140269T3 (pl) Podpis białkowy/znaczniki do wykrywania gruczolakoraka
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
WO2011047087A3 (en) Protein detection via nanoreporters
MX340453B (es) Biomarcadores para cancer de pulmon.
GB0724881D0 (en) Methods for the detection of colorectal cancer
ATE518860T1 (de) Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
MX2009008470A (es) Particulas para detectar objetivos intracelulares.
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
EP2518158A4 (en) PANCREATIC CANCER MARKERS, METHODS, KITS AND DETECTION BIOPUCES THEREFOR
DK2135091T3 (da) MS-fremgangsmåder til evaluering af glykaner
EA201190210A1 (ru) Ингибиторы связывания киназы с белком
DK3106874T3 (da) Fremgangsmåde til detektering af cancer
EP2281903A4 (en) CANCER MARKER, METHOD FOR EVALUATING CANCER USING THE CANCER MARKER AND ASSESSING THE VALUE
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
NO20073356L (no) Dampkompresjons-kjolesystem med lukket krets samt fremgangsmate for drift av systemet.
DK1987357T3 (da) Polypeptider, som genkendes af anti-Trichinella-antistoffer, og anvendelser deraf
WO2012167163A3 (en) Methods and compositions for detecting endometrial or ovarian cancer